Industrial Component Helium Leak Testing: Routine QC Beyond Pharmaceutical Packaging

Overview

PTI applies the same core helium mass-spectrometer technology used for drug-container CCI to welded assemblies, valve bodies, coated test coupons, and similar precision-manufactured parts. The sample here is never a pharmaceutical primary container; it is a dry, non-drug-contact manufactured part submitted as part of a client's own production quality-control or incoming-inspection workflow.

Two complementary techniques cover the range of part geometries encountered. In spray-probe testing, the part is connected to vacuum and helium gas is sprayed externally over welds, seams, and joints; any leak path draws helium into the part and to the connected mass spectrometer. In sniffer-probe testing, the relationship is reversed: helium is introduced into the part's interior, and a handheld sniffer probe is passed over the exterior surface to detect helium escaping through a leak path — often the more practical approach for complex external geometries.

Sample & Container Type

• Manufactured metal and composite components — welded assemblies, valve bodies, coated test coupons
• Precision-manufactured parts, not pharmaceutical primary packaging
• Submitted as part of the client's own manufacturing or incoming-inspection process

Product Class & Rheology

• Not a pharmaceutical product class — dry, non-drug-contact industrial and mechanical parts
• Routine leak-rate quality control rather than a one-time development study
• Acceptance limits reflect the client's own engineering requirements rather than a pharmaceutical MALL

General Test Method

Each testing session opens and closes with verification against a certified external leak standard, and every part is measured against a client-specified acceptance limit (commonly expressed in atm·cc/sec or mbar·L/sec). Because this is typically a routine, recurring QC service, the protocol is built for high-volume, repeatable throughput rather than a one-time study.

Typical Findings & Sensitivity

The large majority of submitted parts test at or near instrument background, well within typical acceptance limits, giving clients strong ongoing confidence in their welding, casting, or coating processes. Occasional failing parts are usually readily distinguishable from the passing population by an order-of-magnitude or larger difference in leak rate, supporting straightforward pass/fail dispositioning and, where requested, trend tracking across production lots over time.

Frequently Asked Questions

1. What kinds of parts get tested with this application?

Welded metal fittings, cast valve bodies, coated test coupons used to qualify a surface-treatment or bonding process, and similar precision-manufactured mechanical or industrial parts.

2. What's the difference between spray-probe and sniffer-probe testing?

Spray-probe testing evacuates the part and sprays helium externally over welds and joints; sniffer-probe testing pressurizes the part with helium internally and scans the exterior with a handheld probe. The choice depends on part geometry and which is more practical to pressurize or evacuate.

3.Is this a one-time test or an ongoing QC service?

Typically an ongoing, recurring QC service tied to the client's production cadence, with results delivered per batch or shipment rather than as a single development study.

4. What acceptance limits are used for industrial parts?

Limits are client-specified and reflect the client's own engineering requirements, commonly expressed in atm·cc/sec or mbar·L/sec, rather than a pharmaceutical Maximum Allowable Leakage Limit.

5. Can PTI provide trend tracking across production lots?

Yes — for clients who submit parts on a recurring basis, a running record makes it possible to spot a gradual drift in a supplier's or process's leak-rate performance before it would otherwise be noticed.

Why Clients Choose PTI for This Application

This application demonstrates that PTI's core competency — precise, quantitative, small-leak detection — is a general-purpose capability well beyond pharmaceutical packaging, giving industrial clients a defensible, third-party-verifiable leak-rate result structured around their own production cadence.